164 related articles for article (PubMed ID: 21401607)
1. Montelukast, a cysteinyl leukotriene receptor-1 antagonist, attenuates chronic brain injury after focal cerebral ischaemia in mice and rats.
Zhao R; Shi WZ; Zhang YM; Fang SH; Wei EQ
J Pharm Pharmacol; 2011 Apr; 63(4):550-7. PubMed ID: 21401607
[TBL] [Abstract][Full Text] [Related]
2. Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice.
Yu GL; Wei EQ; Zhang SH; Xu HM; Chu LS; Zhang WP; Zhang Q; Chen Z; Mei RH; Zhao MH
Pharmacology; 2005 Jan; 73(1):31-40. PubMed ID: 15452361
[TBL] [Abstract][Full Text] [Related]
3. Intracerebroventricular injection of HAMI 3379, a selective cysteinyl leukotriene receptor 2 antagonist, protects against acute brain injury after focal cerebral ischemia in rats.
Shi QJ; Xiao L; Zhao B; Zhang XY; Wang XR; Xu DM; Yu SY; Fang SH; Lu YB; Zhang WP; Sa XY; Wei EQ
Brain Res; 2012 Nov; 1484():57-67. PubMed ID: 23000196
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of cysteinyl leukotriene receptor-1 in the brain mediates neuronal damage and astrogliosis after focal cerebral ischemia in rats.
Fang SH; Wei EQ; Zhou Y; Wang ML; Zhang WP; Yu GL; Chu LS; Chen Z
Neuroscience; 2006 Jul; 140(3):969-79. PubMed ID: 16650938
[TBL] [Abstract][Full Text] [Related]
5. HAMI 3379, a CysLT2R antagonist, dose- and time-dependently attenuates brain injury and inhibits microglial inflammation after focal cerebral ischemia in rats.
Shi QJ; Wang H; Liu ZX; Fang SH; Song XM; Lu YB; Zhang WP; Sa XY; Ying HZ; Wei EQ
Neuroscience; 2015 Apr; 291():53-69. PubMed ID: 25681271
[TBL] [Abstract][Full Text] [Related]
6. Cysteinyl leukotriene receptor (CysLT) antagonists decrease pentylenetetrazol-induced seizures and blood-brain barrier dysfunction.
Lenz QF; Arroyo DS; Temp FR; Poersch AB; Masson CJ; Jesse AC; Marafiga JR; Reschke CR; Iribarren P; Mello CF
Neuroscience; 2014 Sep; 277():859-71. PubMed ID: 25090924
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effect of ONO-1078, a leukotriene receptor antagonist, on focal cerebral ischemia in rats.
Zhang WP; Wei EQ; Mei RH; Zhu CY; Zhao MH
Acta Pharmacol Sin; 2002 Oct; 23(10):871-7. PubMed ID: 12370090
[TBL] [Abstract][Full Text] [Related]
8. Montelukast, a cysteinyl leukotriene receptor-1 antagonist protects against hippocampal injury induced by transient global cerebral ischemia and reperfusion in rats.
Saad MA; Abdelsalam RM; Kenawy SA; Attia AS
Neurochem Res; 2015 Jan; 40(1):139-50. PubMed ID: 25403620
[TBL] [Abstract][Full Text] [Related]
9. Montelukast attenuates neuropathic pain through inhibiting p38 mitogen-activated protein kinase and nuclear factor-kappa B in a rat model of chronic constriction injury.
Zhou C; Shi X; Huang H; Zhu Y; Wu Y
Anesth Analg; 2014 May; 118(5):1090-6. PubMed ID: 24686047
[TBL] [Abstract][Full Text] [Related]
10. Edaravone, a free radical scavenger, attenuates cerebral infarction and hemorrhagic infarction in rats with hyperglycemia.
Okamura K; Tsubokawa T; Johshita H; Miyazaki H; Shiokawa Y
Neurol Res; 2014 Jan; 36(1):65-9. PubMed ID: 24074041
[TBL] [Abstract][Full Text] [Related]
11. Montelukast protects axial pattern rat skin flaps against ischemia/reperfusion injury.
Gideroglu K; Yilmaz F; Aksoy F; Bugdayci G; Saglam I; Yimaz F
J Surg Res; 2009 Dec; 157(2):181-6. PubMed ID: 19589545
[TBL] [Abstract][Full Text] [Related]
12. Treatment with edaravone attenuates ischemic brain injury and inhibits neurogenesis in the subventricular zone of adult rats after focal cerebral ischemia and reperfusion injury.
Zhang P; Li W; Li L; Wang N; Li X; Gao M; Zheng J; Lei S; Chen X; Lu H; Liu Y
Neuroscience; 2012 Jan; 201():297-306. PubMed ID: 22116052
[TBL] [Abstract][Full Text] [Related]
13. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
Muz MH; Deveci F; Bulut Y; Ilhan N; Yekeler H; Turgut T
Exp Mol Med; 2006 Apr; 38(2):109-18. PubMed ID: 16672764
[TBL] [Abstract][Full Text] [Related]
14. Montelukast inhibits caspase-3 activity and ameliorates oxidative damage in the spinal cord and urinary bladder of rats with spinal cord injury.
Erşahin M; Çevik Ö; Akakın D; Şener A; Özbay L; Yegen BC; Şener G
Prostaglandins Other Lipid Mediat; 2012 Dec; 99(3-4):131-9. PubMed ID: 22986158
[TBL] [Abstract][Full Text] [Related]
15. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
Shimbori C; Shiota N; Okunishi H
Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
[TBL] [Abstract][Full Text] [Related]
16. The leukotriene d4 receptor antagonist, montelukast, inhibits mast cell degranulation in the dermis induced by water avoidance stress.
Cikler E; Ersoy Y; Cetinel S; Ercan F
Acta Histochem; 2009; 111(2):112-8. PubMed ID: 18617226
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic potential of montelukast against mild colitis induced by dextran sulphate sodium in rats.
Holma R; Salmenperä P; Virtanen I; Vapaatalo H; Korpela R
J Physiol Pharmacol; 2007 Sep; 58(3):455-67. PubMed ID: 17928642
[TBL] [Abstract][Full Text] [Related]
18. Montelukast, a selective cysteinyl leukotriene receptor 1 antagonist, reduces cerulein-induced pancreatic injury in rats.
Ozkan E; Akyüz C; Sehirli AO; Topaloğlu U; Ercan F; Sener G
Pancreas; 2010 Oct; 39(7):1041-6. PubMed ID: 20467345
[TBL] [Abstract][Full Text] [Related]
19. Cysteinyl-leukotriene receptor antagonist montelukast decreases blood-brain barrier permeability but does not prevent oedema formation in traumatic brain injury.
Biber N; Toklu HZ; Solakoglu S; Gultomruk M; Hakan T; Berkman Z; Dulger FG
Brain Inj; 2009 Jun; 23(6):577-84. PubMed ID: 19484631
[TBL] [Abstract][Full Text] [Related]
20. Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication.
Muraki M; Imbe S; Sato R; Ikeda Y; Yamagata S; Iwanaga T; Tohda Y
Int Immunopharmacol; 2009 Oct; 9(11):1337-41. PubMed ID: 19706339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
